Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.4)
Index Copernicus  – 161.11; MEiN – 140 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2017, vol. 26, nr 1, January-February, p. 135–141

doi: 10.17219/acem/61908

Publication type: review article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

“From right to left”: The role of right heart catheterization in the diagnosis and management of left heart diseases

Marta Kałużna-Oleksy1,A,B,C,D,E,F, Aleksander Araszkiewicz1,C,D,E,F, Jacek Migaj1,B,E,F, Maciej Lesiak1,E,F, Ewa Straburzyńska-Migaj1,A,E,F

1 1st Department of Cardiology, Poznan University of Medical Sciences, Poland


Pulmonary hypertension (PH), second only to left heart diseases (LHD), is a frequent problem in clinical practice. At the same time, left heart diseases represent the most common cause of pulmonary hypertension, and the occurrence of PH in patients with chronic heart failure is usually associated with worse functional class, and prognosis. Right heart catheterization (RHC) is the “gold standard” in the diagnosis and differentiation of PH. It is also essential in the process of qualifying for a heart transplantation. Therefore, right heart catheterization should be performed in expert centers by experienced operators and according to a strict protocol to ensure the reliability and reproducibility of results. Recommendations for pulmonary hypertension due to left heart disease are based on the European Society of Cardiology (ESC) guidelines designed in cooperation with the European Respiratory Society (ERS) and the International Society for Heart and Lung Transplantation (ISHL). The new ESC guidelines for pulmonary hypertension published in 2015 have improved the diagnostic and therapeutic process in patients with left heart diseases.

Key words

pulmonary hypertension, right heart catheterization, left heart disease

References (40)

  1. Guglin M, Khan H. Pulmonary hypertension in heart failure. J Card Fail. 2010;16:461–474.
  2. Guazzi M, Arena R. Pulmonary hypertension with left-sided heart disease. Nat Rev Cardiol. 2010;7:648–659.
  3. Hoeper MM, Barbera JA, Channick RN, et al. Diagnosis, assessment and treatment of non-pulmonary arterial hypertension pulmonary hyper-tension. J Am Coll Cardiol. 2009;54:S85–S96.
  4. Ghio S, Gavazzi A, Campana C, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 2001;37:183–188.
  5. Abramson SV, Burke JF, Kelly JJ Jr, et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med. 1992;116:888–895.
  6. Kurzyna M, Araszkiewicz A, Błaszczak P, et al. Standardy hemodynamicznej i angiograficznej oceny krążenia płucnego. Kardiol Pol. 2014;72:45–64.
  7. Kurzyna M, Araszkiewicz A, Błaszczak P, et al. Summary of recommendations for the haemodynamic and angiographic assessment of the Polish Cardiac Society’s Working Group on Pulmonary Circulation and Association of Cardiovascular Interventions. Kardiol Pol. 2015;73(1):63–68.
  8. Galié N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) [Epub ahead of print]. Eur Heart J. 2015. doi:10.1093/eurheartj/ehv317.
  9. Urbanowicz T, Straburzyńska-Migaj E, Katyńska I, et al. Sustained improvement of clinical status and pulmonary hypertension in patients with severe heart failure treated with sildenafil. Ann Transplant. 2014;19:325–330.
  10. Galié N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diag-nosis and Treatment of Pulmonary Hypertension of the European Society of Cardilogy (ESC) and the European Respiratory Society (ERS), en-dorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30:2493–2537.
  11. Vachiery JL, Adir Y, Barbera JA, et al. Pulmonary hypertension due to left heart disease. J Am Coll Cardiol. 2013;62:D100–D108.
  12. Haddad F, Kudelko K, Mercier O, Vrtovec B, Zamanian RT, de Jesus Perez V. Pulmonary hypertension associated with left heart disease: char-acteristics, emerging concepts, and treatment strategies. Prog Cardiovasc Dis. 2011;54:154–167.
  13. Forssmann W. The catheterization of the right side of the heart. Klin Wochenschr. 1929;45:2085–2087.
  14. Cournand A. Catheterization of the right auricle in man. Proc Soc Exp Biol Med. 1941;46:462–466.
  15. Cournand A, Bloomfield RA. Recording of right pressure in man. Proc Soc Exp Biol Med. 1944;55:34–36.
  16. Swan HJ, Ganz W, Forrester J, Marcus H, Diamond G, Chonette D. Catheterization of the heart in man with use of a flow-directed bal-loon-tipped catheter. N Engl J Med. 1970;283(9):447–451.
  17. Ganz W, Donoso R, Marcus HS, Forrester JS, Swan HJ. A new technique for measurment of cardiac output by thermodilution in man. Am J Cardiol. 1971;27:392–396.
  18. Connors AF, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT investigators. JAMA. 1996;276:889–897.
  19. Harvey S, Harrison DA, Singer M, et al. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): A randomized controlled trial. Lancet. 2005;366:472–477.
  20. The ESCAPE Investigators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial. JAMA. 2005;294:1625–1633.
  21. Kahwash R, Leier CV, Miller L. Role of the pulmonary artery catheter in diagnosis and management of heart failure. Cardiol Clin. 2011;29:281–288.
  22. Thenappan T, Shah SJ, Gomberg-Maitland M, et al. Clinical characteristics of pulmonary hypertension in patients with heart failure and pre-served ejection fraction. Circ Heart Fail. 2011;4:257–265.
  23. Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedure in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol. 2006;48:2546–2552.
  24. American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization. Practice guidelines for pulmonary artery catheter-ization: An updated report by the American Society of Anesthesiology Task Force on Pulmonary Artery Catheterization. Anesthesiology. 2003;99:988–1014.
  25. Kovacs G, Avian A, Olschewski A, Olschewski H. Zero reference level for right heart catheterization. Eur Respir J. 2013;42:1586–1594.
  26. Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D42–50.
  27. Hoeper MM, Maier R, Tongers J, et al. Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension. Am J Respir Crit Care Med. 1999; 160:535–541.
  28. Paulus WJ, Tschöpe C, Sanderson JE, et al. How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28:2539–2550.
  29. Frost AE, Farber HW, Barst RJ, Miller DP, Elliott CG, McGoon MD. Demographics and outcomes of patients diagnosed with pulmonary hyper-tension with pulmonary capillary wedge pressures 16 to 18 mm Hg: Insights from the REVEAL Registry. Chest. 2013;143:185–195.
  30. Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial. Lancet. 2011;377:658–666.
  31. Fujimoto N, Borlaug BA, Lewis GD, et al. Hemodynamic responses to rapid saline loading: The impact of age, sex, and heart failure. Circula-tion. 2013;127:55–62.
  32. Robbins IM, Hemnes AR, Pugh ME, et al. High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Circ Heart Fail. 2014;7:116–122.
  33. Costanzo MR, Augustine S, Bourge R, et al. Selection and treatment of candidates for heart transplantation. A statement for health profes-sionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1995;92:3593–3612.
  34. Chang PP, Longenecker JC, Wang NY, et al. Mild vs severe pulmonary hypertension before heart transplantation: Different effects on post-transplantation pulmonary hypertension and mortality. J Heart Lung Transplant. 2005;24:998–1007.
  35. Costard-Jackle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: Testing of po-tential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 1992;19:48–54.
  36. Mehra MR, Kobashigawa J, Starling R, et al. Listing criteria for heart transplantation: International Society of Heart and Lung Transplantation Guidelines for the care of cardiac transplant candidates – 2006. J Heart Lung Transplant. 2006;25:1024–1042.
  37. Halpern SD, Taichmann DB. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. Chest. 2009;136:37–43.
  38. Swierad M, Zakliczynski M, Maruszewski M, et al. Reversibility of pulmonary hypertension assessment as an expected standard of diagnosis and prognosis on cardiology ward in Poland. Kardiol Pol. 2009;67:106–109.
  39. Francis GS, Greenberg BH, Hsu DT, et al. ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant: A report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training. J Am Coll Cardiol. 2010;56:424–453.
  40. Zakliczynski M, Zebik T, Maruszewski M, Swierad M, Zembala M. Usefulness of pulmonary hypertension reversibility test with sodium nitro-prusside in stratification of early death risk after orthotopic heart transplantation. Transplant Proc. 2005;37:1346–1348.